AstraZeneca PLC ADR AZN,
fell 1.41% to $ 50.19 Thursday, in what proved to be a big trading session for the stock market, with the NASDAQ Composite Index COMP,
increasing 2.56% to 13,067.48 and the Dow Jones Industrial Average DJIA,
rising 0.69% to 31,041.13. The drop in ADR resulted in three consecutive days of victories. AstraZeneca PLC ADR closed $ 14.75 short of its 52-week high ($ 64.94), which the company achieved on July 20.
ADR underperformed when compared to some of its competitors on Thursday, like AbbVie Inc. ABBV,
rose 1.07% to $ 106.71, Amgen Inc. AMGN,
rose 0.33% to $ 234.02, and Gilead Sciences Inc. GILD,
rose 0.92% to $ 62.52. Turnover (13.6 M) exceeded its average 50-day volume of 10.2 M.
Editor’s note: this story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.